| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
|
Hebert, M.F
|
|
1997
|
27 |
2-3 |
p. 201-214
14 p.
|
artikel
|
| 2 |
Editorial
|
|
|
1997
|
27 |
2-3 |
p. 97-98
2 p.
|
artikel
|
| 3 |
Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction
|
Thummel, Kenneth E.
|
|
1997
|
27 |
2-3 |
p. 99-127
29 p.
|
artikel
|
| 4 |
Human immunodeficiency virus protease inhibitors
|
Lin, Jiunn H.
|
|
1997
|
27 |
2-3 |
p. 215-233
19 p.
|
artikel
|
| 5 |
Impact of P450 genetic polymorphism on the first-pass extraction of cardiovascular and neuroactive drugs 1 Supported by the Robert Bosch Foundation, Stuttgart, Germany. 1
|
Fromm, Martin F
|
|
1997
|
27 |
2-3 |
p. 171-199
29 p.
|
artikel
|
| 6 |
Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies
|
Pauletti, Giovanni M.
|
|
1997
|
27 |
2-3 |
p. 235-256
22 p.
|
artikel
|
| 7 |
The barrier function of CYP3A4 and P-glycoprotein in the small bowel
|
Watkins, Paul B
|
|
1997
|
27 |
2-3 |
p. 161-170
10 p.
|
artikel
|
| 8 |
The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans
|
Wilkinson, Grant R
|
|
1997
|
27 |
2-3 |
p. 129-159
31 p.
|
artikel
|
Tijdschrift beschrijving